Trial Profile
Avonex Pregnancy Exposure Registry
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jun 2015
Price :
$35
*
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- Sponsors Biogen
- 29 Sep 2011 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
- 29 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Apr 2011 Planned End Date changed from 1 Aug 2010 to 1 Aug 2011 as reported by ClinicalTrials.gov.